EPCORITAMAB WITH GEMCITABINE, DEXAMETHASONE, AND CISPLATIN (EPCO-GDP) IN RELAPSED REFRACTORY LARGE B-CELL LYMPHOMA – AN INTERIM ANALYSIS OF PHASE II MULTICENTER INVESTIGATED-INITIATED TRIAL